Enzalutamide drug proves effective in stemming progression of prostate cancer

[News]

A drug used to treat men with late-stage prostate cancer proved effective in stemming progression of the disease in research participants who had not yet received chemotherapy and extended their survival, according to results from a multi-national Phase III clinical trial led by the Knight Cancer Institute at Oregon Health & Science University.

More... (http://www.news-medical.net/news/20140603/Enzalutamide-drug-proves-effective-in-stemming-progression-of-prostate-cancer.aspx)